A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
NCT03055611
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Berlin, Germany
View Trial DetailsNCT Number: NCT02049099
To describe the current treatment practice during 12 months for previously treated patients diagnosed with haemophilia A or haemophilia B.
Looking for future studies?
Notify Me2 year and older
Male
Observational
Swedish Orphan Biovitrum Investigational Site, Brussels, Belgium
The study population consists of patients with a diagnosis of ICD10: haemophilia A D66.9 or haemophilia B D67.9.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: - 12 month to Day 0
Time frame: - 12 month to Day 0
Swedish Orphan Biovitrum
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03055611
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Berlin, Germany
View Trial DetailsNCT03276130
Anxiety Disorders, Blood Coagulation Disorders
Copenhagen, Denmark
View Trial DetailsNCT03741881
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Los Angeles, California, United States
View Trial DetailsNCT03660774
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited
Los Angeles, California, United States
View Trial Details